Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A Poor Prognosis Subtype of HNSCC Is Consistently Observed across Methylome, Transcriptome, and miRNome Analysis

11 Jun 2013

Abstract excerpt

PURPOSE: Distant metastasis after treatment is observed in about 20% of squamous cell carcinoma of the head and neck (HNSCC). In the absence of any validated robust biomarker, patients at higher risk for metastasis cannot be provided with tailored therapy. To identify prognostic HNSCC molecular subgroups and potential biomarkers, we have conducted genome-wide integrated analysis of four omic sets of data....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Esophageal Cancer Research and Treatment
Share to Head and Neck Cancer Studies
Share to MicroRNA in disease regulation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 23757353
DOI: 10.1158/1078-0432.ccr-12-3690

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A Poor Prognosis Subtype of HNSCC Is Consistently Observed across Methylome, Transcriptome, and miRNome AnalysisPMID 23757353Read ↗

Integrative Multiomics Analyses Identify Molecular Subtypes of Head and Neck Squamous Cell Carcinoma with Distinct Therapeutic Vulnerabilities.Semantic proximity Read ↗

Integrated Multi-Omics Signature Predicts Survival in Head and Neck CancerSemantic proximity Read ↗

Transcriptomics and Epigenomics in head and neck cancer: available repositories and molecular signaturesSemantic proximity Read ↗

Integrative immune subtyping of HNSCC reveals clinically relevant phenotypes and treatment-associated transitionsSemantic proximity Read ↗

A multi-omics approach to identify prognostic subtypes and therapeutic targets in head and neck squamous cell carcinomaSemantic proximity Read ↗

Multi‑omics analysis identifies different molecular subtypes with unique outcomes in early-stage poorly differentiated lung adenocarcinomaSemantic proximity Read ↗

Clinical-genomic determinants of immune checkpoint blockade response in head and neck squamous cell carcinoma.Semantic proximity Read ↗

Multi‑omics analysis identifies different molecular subtypes with unique outcomes in early-stage poorly differentiated lung adenocarcinomaSemantic proximity Read ↗

Integrative analysis in head and neck cancer reveals distinct role of miRNome and methylome as tumour epigenetic driversSemantic proximity Read ↗

Novel insights into head and neck cancer using next-generation "omic" technologies.Semantic proximity Read ↗

Integrative Single-Cell and Bulk Transcriptomes Analyses Identify Intrinsic HNSCC Subtypes with Distinct Prognoses and Therapeutic VulnerabilitiesSemantic proximity Read ↗

Single‐cell sequencing of head and neck carcinoma: Transcriptional landscape and prognostic model based on malignant epithelial cell featuresSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.